Association between lower limb osteoarthritis and incidence of depressive symptoms: data from the Osteoarthritis Initiative by Veronese, Nicola et al.
1 
 
ASSOCIATION BETWEEN LOWER LIMB OSTEOARTHRITIS  
AND INCIDENCE OF DEPRESSIVE SYMPTOMS:  
DATA FROM THE OSTEOARTHRITIS INITIATIVE 
 
 
Nicola Veronese, MDa,b*, Brendon Stubbs, PhDc,d,e*, Marco Solmi, MD b,f,g, Toby O Smith, PhDh, 
Marianna Noale, ScDi, Cyrus Cooper,MDl,m,n, Stefania Maggi, MDi 
 
* Veronese and Stubbs are joint first authors.  
 
a Department of Medicine (DIMED), Geriatrics Division, University of Padova, Italy. 
b Institute of clinical Research and Education in Medicine (IREM), Padova, Italy 
c Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, 
London SE5 8AZ, United Kingdom.  
d Health Service and Population Research Department, Institute of Psychiatry, King's College 
London, De Crespigny Park, London SE5 8 AF, United Kingdom. 
e Faculty of Health, Social Care and Education, Anglia Ruskin University, Bishop Hall Lane, 
Chelmsford CM1 1SQ, UK 
f Department of Neurosciences, University of Padova, Padova, Italy. 
gNational Health Care System, Padua Local Unit ULSS 17, Italy. 
h Faculty of Medicine and Health Sciences, University of East Anglia, Norwich Research Park, 
Norwich, NR4 7TJ, United Kingdom. 
i National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy. 
l Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, 
Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, 
Windmill Road, Oxford, OX3 7LD, UK. 
2 
 
m MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, 
Southampton, SO16 6YD, UK. 
n National Institute for Health Research Nutrition Biomedical Research Centre, University of 
Southampton and University Hospital Southampton NHS Foundation Trust, Southampton General 
Hospital, Southampton, SO16 6YD, UK. 
 
Corresponding Author: 
Nicola Veronese, MD 
Department of Medicine - DIMED, Geriatrics Division, University of Padova, Padova, Italy 
Via Giustiniani, 2 - 35128 Padova, Italy 
Phone: +39 0498218492; Fax: +39 0498211218 
Email: ilmannato@gmail.com  
 
3 
 
ABSTRACT 
Background: Osteoarthritis (OA) is associated with a number of medical morbidities. Although the 
prevalence of depression and depressive symptoms is presumed to be high in people with OA, no 
prospective comparative study has analyzed its incidence. 
Objective: To determine whether OA was associated with an increased odds of developing 
depressive symptoms.  
Design: Longitudinal cohort study (follow-up: four years).  
Setting: Data were gathered from the North American Osteoarthritis Initiative (OAI) dataset.  
Subjects: People at higher risk developing OA.  
Methods: Osteoarthritis diagnosis was defined as the presence of OA at hand, knee, hip, back/neck 
or other sites at baseline. Depressive symptoms were defined using the 20-item Center for 
Epidemiologic Studies-Depression (cut-off 16 points) after four years.  
Results:  3,491 people without depressive symptoms at baseline were analyzed (1,506 with 
OA/1,985 without). Using an adjusted logistic regression analysis for 12 potential confounders, 
people with OA had a similar odds of depressive symptoms at follow-up compared to those without 
OA (Odds Ratio (OR): 1.26; 95% CI: 0.95-1.67). However, multisite OA (i.e. OA 2>sites; OR: 1.48, 
95% CI 1.07-2.05) and the specific presence of hip (OR: 1.72; 95% CI: 1.08-2.73) or knee OA (OR: 
1.43; 95% CI: 1.03-1.98) were associated with a greater odds of developing depressive symptoms 
compared to people without OA. 
Conclusions: This is the first study of longitudinal data to demonstrate people with multi-site, hip 
or knee OA have a greater odds of developing depressive symptoms compared to people without 
OA.  This suggests that OA may be associated with future mental health burden.   
 
Keywords: osteoarthritis; depression; depressive symptoms; epidemiology.    
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KEY-POINTS 
 In cross-sectional studies, osteoarthritis is associated with a higher prevalence of depression and 
depressive symptoms.  
 It is unknown if osteoarthritis could increase the odds of developing depressive symptoms. 
 We demonstrated that hip, knee or multi-site osteoarthritis increases the odds of depressive 
symptoms. 
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INTRODUCTION 
Recent global burden of disease surveys have demonstrated that whilst average life expectancy is 
rising[1], the number of years people are living with chronic disabilities is also rising.  One of the 
most common causes of years lived with disability are chronic musculoskeletal disorders. [1] 
Osteoarthritis (OA) accounts for a considerable proportion of this burden[2], with hip and knee OA 
ranked the 11th highest contributor to global disability.[2] The worldwide prevalence of OA has 
been estimated to be 10% in men and 20% in women in older people. [2]  
 
A common feature of OA is pain.[3] Pain has been closely linked to incident depression.[4] Pain 
and depression are also associated with poorer outcomes among people with OA.[5] People with 
chronic painful conditions are at increased risk of a range of suicidal behaviors.[6] There are a 
number of reasons that could increase the risk of depression and depressive symptoms in people 
with OA. For instance, OA is associated with increasing disability and difficulty undertaking 
activities of daily living,[7] and with lower quality of life.[2] Furthermore, people with OA often 
engage in less physical activity compared to those without OA [8], whilst lower levels of physical 
activity is a risk factor for future depression.[9]  
 
Depression and depressive symptoms are seen in a proportion of the OA population. A recent meta-
analysis demonstrated that the prevalence of these conditions is approximately 20% in the OA 
population.[10] The authors acknowledged a lack of comparative studies comparing the prevalence 
of depression/depressive symptoms in OA compared to non-OA cohorts. It has therefore not been 
possible to establish if depressive symptoms are more common in people with OA. There has also 
been an absence of longitudinal studies investigated the incidence of depression and depressive 
symptoms in this population. [10]  
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The purpose of this study was to address this limitation and to determine whether:  i) people with 
OA are at greater odds of incident depressive symptoms compared to people without OA; ii) the 
location of OA (e.g. hand, hip, knee, back/neck) related to the incidence of depressive symptoms; 
and iii) multisite OA was associated with odds of developing depressive symptoms than single-site 
presentations.   
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METHODS 
Data source and subjects 
All participants in this study were recruited as part of the ongoing, publicly and privately-funded, 
multicenter Osteoarthritis Initiative (OAI) study, which is available for public access 
(http://www.oai.ucsf.edu/). Patients were recruited from four clinical sites in the US (Baltimore, 
MD; Pittsburgh, PA; Pawtucket, RI; and Columbus, OH) between February 2004 and May 2006. 
People were eligible if they: i) had knee osteoarthritis and reported knee pain in a 30-day period in 
the past 12 months; or ii) were at high risk of developing knee OA (e.g. overweight/obese, knee 
injury/operation, parents/siblings with total knee replacement, frequent knee-bending activities that 
increase risk, and hand/hip osteoarthritis). All participants provided written informed consent.  
 
The OAI study protocol was approved by the institutional review board of the OAI Coordinating 
Center, University of California at San Francisco. Specific datasets used were those recorded during 
baseline and screening evaluations (November 2008) and those evaluating the participants after 48 
months. 
 
Exposure 
The diagnosis for OA at baseline assessment  was self-reported for the most common sites usually 
affected by OA (knee, hand, hip, back/neck, and other).  Through this participant were asked if a 
doctor, at any time in his/her life, had said that he/she suffers from OA. A summary variable 
ascertained as the presence of at least one site affected by self-reported OA was then calculated. 
Multisite OA was defined as the presence of two or more affected sites.  Radiological data were 
available for those with knee OA. Accordingly, a separate analysis was undertaken where knee OA 
was defined as a combination of self-reported symptoms of pain and stiffness, and radiographical 
confirmation of OA based on the presence of tibiofemoral osteophytes on a fixed flexion radiograph 
(as per Osteoarthritis Research Society International atlas grades 1-3, clinical center reading).   
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Outcomes 
The presence of depressive symptoms was derived from the 20-item Center for Epidemiologic 
Studies-Depression (CES-D) instrument.[11] The range of possible values for this scores is 0 to 60, 
where higher scores indicate more depressive symptoms.[11] A cut-off of 16 was used for the 
diagnosis of depressive symptoms. [12]  
 
Covariates 
A number of variables were identified from the OAI dataset to explore associations between OA 
and incident depressive symptoms. These included: (1) physical activity, evaluated using the 
Physical Activity Scale for the Elderly (PASE), a validated scale for assessing physical activity 
level in the elderly.[13] The scale covers 12 different activities including: walking, sports and 
housework, and is scored from 0 upwards, without a maximum score; (2) race was defined as 
“whites” vs. others; (3) smoking habits as “previous/current” vs. never; (4) educational level was 
categorized as “degree” vs. others; (5) yearly income as < and missing data vs. > 50,000 $; and (6) 
medical co-morbidities were assessed through the modified Charlson Comorbidity Index (CCI), 
where higher scores indicate an greater number of morbidities and poorer health.[14] Among the 
several medical conditions assessed through the CCI, prevalence was reported for the more 
common diseases associated with OA and depressive symptoms (i.e. fractures, heart failure, heart 
attack, stroke, chronic obstructive pulmonary disease (COPD), diabetes and cancer).  
 
Statistical analyses 
For continuous variables, data normality was assessed using the Kolmogorov-Smirnov test. The 
data were presented as means and standard deviations (SD) for quantitative measures, and 
frequency and percentages for discrete variables by OA presence. P-values were calculated for 
continuous variables using the independent Student T-test and for categorical parameters the chi-
square test.  
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The incidence of depressive symptoms was calculated as the number of new cases per 1000 person-
years during the follow-up. The proportional hazards assumption was evaluated by plotting the 
Schoenfeld residuals versus time. Since this was reported as p<0.0001, a logistic regression 
analysis, rather than a Cox’s proportional hazard models was used. Multivariate logistic binary 
regression models were constructed using the presence of OA as the exposure and incident 
depressive symptoms at four-year follow-up as the outcome. The multivariate model included the 
confounding factors that were  significantly different between participants with and without OA  at 
baseline or were significantly associated with incident depressive symptoms at follow-up. Multi-
collinearity among covariates was assessed through variance inflation factor (VIF), taking a cut-off 
of 2 as reason for exclusion. No variable was excluded for this reason. The basic model was not 
adjusted for any confounders, while the fully adjusted model included baseline values of: age (as 
continuous); gender; race (whites vs. others); Body Mass Index (BMI; as continuous); education 
(degree vs. others); smoking habits (current and previous vs. others); yearly income (categorized as 
> or < 50,000$ and missing data); PASE (as continuous); CCI and baseline CES-D. Changes in CCI 
during baseline and follow-up evaluations and the onset of new OA cases during the follow-up 
period were also introduced to the fully-adjusted model. Data of logistic binary analyses were 
reported as odds ratios (ORs) with 95% confidence intervals (CIs).  
 
On secondary analyses, specific sites affected by OA (categorized as presence of hand, hip, knee, 
back/neck, or other) and presence of multi-site OA (>2 sites affected by OA) were taken as 
exposure variables. Participants without OA were taken as the reference throughout these analyses.   
 
To test the robustness of our findings, sensitivity analyses were conducted evaluating the interaction 
between the presence of self-reported and radiological with clinical diagnosis of OA and selected 
factors (e.g. age below or more than 65 years, gender, race, education, smoking habits, yearly 
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income and presence/absence of diseases at baseline) in predicting depressive symptoms at follow-
up, without finding any factor significantly influenced  our results.  
 
All analyses were performed using the SPSS 21.0 for Windows (SPSS Inc., Chicago, Illinois). All 
statistical tests were two-tailed and statistical significance was assumed for a p-value <0.05. 
 
Declaration of Sources of Funding 
The OAI is a public-private partnership comprised of five contracts(N01-AR-2-2258; N01-AR-2-
2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of 
Health, a branch of the Department of Health and Human Services, and conducted by the OAI 
Study Investigators. Private funding partners include Merck Research Laboratories; Novartis 
Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI 
is managed by the Foundation for the National Institutes of Health. This manuscript was prepared 
using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI 
investigators, the NIH, or the private funding partners. The funding sources did not have any role in 
in study design; in the collection, analysis and interpretation of data; in the writing of the report; and 
in the decision to submit the article for publication.  
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RESULTS 
Study participants 
At baseline, among 4,796 potentially eligible individuals, 264 were excluded due to missing CES-D 
data, 462 excluded who had a CES-D >16 at baseline and a further 579 participants did not return at 
follow-up evaluation. Accordingly 3,491 participants were eligible for this study. Full details of 
participant flow are presented in Figure 1.   
 
Baseline analyses  
The 3,491 participants (1,474 Males/2,017 Females) had a mean age of 61.3±9.1 (range: 45-79) 
years. At baseline, 1506 people with OA (43.1%) were compared to 1,985 participants without OA.   
 
The baseline characteristics of the OA and non-OA participants are summarized in Table 1. The 
OA participants were more frequently women (62.7 versus 54.1%), white (87.4 versus 80.1%) and 
older (62.8±8.9 versus 60.0±9.2 years) than those without OA (p <0.0001 for all comparisons). 
Individuals with OA had higher BMI values, lower physical activity levels, were more frequently 
smokers and had a higher educational level compared to the non-OA group (Table 1).  Regarding 
medical conditions, participants with OA more frequently reported bone fractures and had a higher 
CCI (Table 1). Finally, participants with OA showed significantly higher CES-D score at baseline 
(5.0±4.1 versus 4.4±3.9, p<0.0001) compared to without OA.  
 
Follow-up analyses and incident depressive symptoms  
After a mean period of 4.2 years, 280 individuals (8.0% of the baseline population) developed 
depressive symptoms, with an incidence of 26 (95% CI: 0 to 87) new cases per 1,000 person-years. 
People with OA had an incidence of depressive symptoms of 27 versus 17 new cases per 1,000 
persons-years.  
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The unadjusted analyses demonstrated that people with OA were at an increased odds of depressive 
symptoms over the four-year follow-up compared to those without (Table 2). However, on logistic 
regression analysis, after adjusting for 12 potential confounders (i.e. age, gender, race, BMI, 
education, smoking habits, yearly income, PASE score, CCI at baseline and follow-up, CES-D 
score at baseline, and presence of new onset of OA during follow-up period), demonstrated that 
having OA at baseline did not significantly increased the odds of depressive symptoms when 
compared to those without OA (OR=1.26; 95% CI: 0.95-1.67, p=0.25; Table 2). These findings 
were evident also after stratifying for age (> 65 years: adjusted OR: 1.33; 95% CI: 0.82-2.14 vs. 
<65 years: OR: 1.23; 95% CI: 0.86-1.75; p=0.84). Similarly, the CES-D scores at follow-up 
evaluation were similar between the OA versus and non-OA groups (6.3±6.2 vs. 5.5±6.2; p=0.14 
adjusted for potential confounders within a generalized linear model). 
 
On multivariate analysis, significant predictors of depressive symptoms were: BMI (one point 
corresponded to an increase in depressive symptoms of 4% OR: 1.04; 95% CI: 1.00-1.07; p=0.01), 
baseline CES-D (one point corresponded to an increase in depressive symptoms of 23%; OR: 1.23; 
95% CI: 1.19-1.27; p<0.0001) and the onset of co-morbidity during follow-up period (OR: 1.25; 
95% CI: 1.08-1.44; p=0.003).   
 
When assessed by specific site, the presence of hip OA (OR: 1.72; 95% CI: 1.08-2.73; p=0.02) and 
knee OA (OR: 1.43; 95% CI: 1.03-1.98; p=0.03) were associated with an increased odds of 
depressive symptoms at the follow-up compared to those without (Table 2). When 
radiological/clinical knee OA was used instead of self-reported knee OA, there was a reduction in 
the strength of association with depressive symptoms, not significant at the p<0.05 level (adjusted 
OR: 1.32; 95% CI: 0.99-1.78; p=0.06). 
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People with multi-site OA (i.e. 2 or more sites affected) were at increased odds of incident 
depressive symptoms compared to those with no OA (OR: 1.48, 95% CI: 1.07-2.05; p=0.03) (Table 
2).  
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DISCUSSION 
This is the first prospective study to determine the incidence of depressive symptoms in people with 
OA compared to a non-OA cohort. People with multi-site OA and those with hip and knee OA have 
a significantly greater odds of developing depressive symptoms compared to those without OA. 
Significant predictors of developing incident depressive symptoms were higher BMI, higher 
baseline CES-D scores and the onset of co-morbidities. 
 
The prevalence of depression and depressive symptoms in people with OA has previously been 
reported as 20%. [10]  However, the cross-sectional nature of these studies meant causality could 
not be determined. Similarly to the increased risk of cardiovascular disease (CVD) in people with 
OA, we hypothesize that the influence of OA on reducing physical activity and increasing 
associated obesity may be the mediating pathway to depression.[15–17]  Whilst physical activity 
was not predictive of incident depression, this may be due to the questionable accuracy of self-
report measures. [18]Moreover, other risk factors such as CVD are also related to incident 
depression[19] and are highly prevalent in people with OA.[20] Finally, higher inflammatory 
markers are frequently evident in people with OA. [21] This may be important in the development 
of depression and depressive symptoms.[22] People with depression, can have an altered peripheral 
immune system, with impaired cellular immunity and increased levels of pro-inflammatory 
cytokines which can influence neurotransmitter metabolism, neuroendocrine function and regional 
brain activity, all of which are relevant to depression. [22] 
 
Previous literature has demonstrated that people with lower limb OA exhibit a number of barriers to 
physical activity[23] and many fail to meet recommended physical activity guidelines.[8] In 
agreement with these observations, our results suggest that hip OA had the strongest association 
with incident depressive symptoms. Lower levels of physical activity are associated with an 
increased risk of future incident depression in the general population.[9] Moreover, exercise has a 
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significant antidepressant effect on people with depression [24]. This therefore provides a further 
rationale for prescribing exercise for people with OA in addition to its well-documented benefits on 
pain, strength and function.[25] . Pain and reduced mobility are common features of OA [26,27]. 
These can become key barriers to physical activity engagement, placing people at greater risk of 
developing depression [9].  Therefore, people with OA may need additional support to help 
maintain or increase their physical activity levels and mobility.  
 
The findings should be considered within the limitations of the study. First, the diagnosis of OA 
was self-reported, except for knee OA. This therefore relies on the individual to accurately recall 
this information. Second, the diagnosis of depressive symptoms was made only using the CES-D. 
Whilst the more formal assessment of the American Psychiatric Association' Diagnostic and 
Statistical Manual [DSM] criteria) was not used, the CES-D used many symptoms defined by the 
(DSM-V) for a major depressive episode and therefore is justifiable.[28] Third, no information was 
available to classify the type of pain (articular, neuropathic or other forms), which may be important 
information for individual’s perceived musculoskeletal symptoms and consequently depression.  
 
In conclusion, this study has demonstrated that people with multi-site, hip and knee OA have a 
significantly greater odds of developing depressive symptoms compared to those without OA. Since 
the incidence of OA is rising with the ageing population, future trials are indicated to determine 
whether intervening can reduce the odds of depressive symptoms occurring, thereby improving this 
population’s physical and mental health into later life.  
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Table 1. Baseline characteristics classified according to presence or not of osteoarthritis 
(OA). 
 
Numbers are mean values (and standard deviations) or number (and percentages), as appropriate. 
 
*Unless otherwise specified, p values are calculated with an independent Student T-test for 
continuous and with a chi-square test for categorical variables, respectively.  
 
Abbreviations: BMI: body mass index; CES-D: Center for Epidemiologic Studies Depression Scale; 
COPD: chronic obstructive pulmonary disease; PASE:  physical activity scale for the elderly. 
Variable Any site OA 
 (n=1,506) 
No OA 
(n=1,985) 
p value* 
Age (years) 62.8 (8.9) 60.0 (9.2) <0.0001 
Females (n, %) 944 (62.7) 1073 (54.1) <0.0001 
White race (n, %) 1315 (87.4) 1588 (80.1) <0.0001 
BMI (Kg/m2) 28.6 (4.7) 28.2 (4.7) 0.04 
PASE (points) 160.6 (80.4) 167.9 (81.4) 0.008 
Smoking (previous/current) 720 (48.0) 857 (43.4) 0.007 
Degree (n, %) 534 (35.5) 631 (31.8) 0.03 
Yearly income (<50,000 $) 946 (65.1) 1284 (66.9) 0.27 
Medical conditions    
Fractures (n, %) 315 (21.0) 310 (15.7) <0.0001 
Heart attack (n, %) 24 (1.7) 40 (2.2) 0.31 
Heart failure (n, %) 27 (1.8) 25 (1.4) 0.88 
Stroke (n, %) 45 (3.1) 46 (2.5) 0.34 
COPD (n, %) 20 (1.4) 37 (2.0) 0.18 
Diabetes (n, %) 97 (6.7) 119 (6.5) 0.89 
Cancer (n, %) 81 (5.4) 91 (4.6) 0.31 
Charlson co-morbidity score 0.4 (0.8) 0.3 (0.8) 0.01 
CES-D (points) 5.0 (4.1) 4.4 (3.9) <0.0001 
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Table 2: Associations between presence of osteoarthritis at the baseline and incident depression.  
 
Unless otherwise specified, data are presented as odds ratios and 95% confidence intervals. 
Notes: 
* Fully-adjusted model included baseline values of: age (as continuous); gender; race (whites vs. others); body mass index (as continuous); 
education (degree vs. others); smoking habits (current and previous vs. others); yearly income (categorized as > or < 50,000$ and missing data); 
 No.  
of events 
No.  
of participants 
Unadjusted 
odds ratio 
(95%CI) 
p 
– value 
Fully-adjusted *  
Model 
odds ratio 
(95%CI) 
p 
–value 
No OA** 137 1985 reference reference 
Presence of OA 143 1506 1.44 (1.12-1.86) 0.005 1.26 (0.95-1.67) 0.10 
Hand OA 57 581 1.53 (1.10-2.15) 0.01 1.24 (0.86-1.81) 0.25 
Hip OA 32 247 2.07 (1.35-3.16) 0.001 1.72 (1.08-2.73) 0.02 
Knee OA 82 783 1.63 (1.21-2.19) 0.001 1.43 (1.03-1.98) 0.03 
Back/neck OA 69 610 1.75 (1.28-2.41) 0.001 1.38 (0.97-1.96) 0.07 
Other sites OA 35 313 1.75 (1.16-2.62) 0.007 1.39 (0.89-2.16) 0.14 
OA at >2 sites 73 618 1.79 (1.33-2.40) <0.0001 1.48 (1.07-2.05) 0.03 
Radiological/clinical knee OA 165 1891 1.28 (0.99-1.67) 0.06 1.32  (0.99-1.78),  0.06 
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physical activity scale for the elderly (as continuous); Charlson co-morbidity index (as continuous) and its value at follow-up; Center for 
Epidemiologic Studies Depression Scale (as continuous); presence of new onset of osteoarthritis during follow-up period. 
** Those without any presence of osteoarthritis were taken as reference in all analyses.   
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Figure 1. Cohort flow-chart.  
 
 
 
 
 
 
 
Patients enrolled in the Osteoarthritis Initiative Project: 4796 
Patients included in the present study: 3491 
CES-D at baseline >16: 
462 
No data about CES-D: 
264 
Lost at follow-
up/deceased: 579 
